Review Article
Clinicopathological and Prognostic Role of Long Noncoding RNA Linc00152 in Various Human Neoplasms: Evidence from Meta-Analysis
Table 1
Main characteristics of included studies in the meta-analysis.
| | Study | Year | Tumor type | Case nationality | Median or mean age | Dominant ethnicity | Study design | Main pathological type | Tumor stage
(I/II/III/IV) | Detected sample | Outcome measures | Source of HR | Maximum months of follow-up |
| | Chen et al. | 2017 | Lung adenocarcinoma | China | 65 | Asian | R | AdenoCA | 24/36 (I-II/IIIa) | Tissue | OS/PFS | SC | 40 | | Wu et al. | 2016 | ccRCC | China | 60 | Asian | R | AdenoCA | 22/55 (I/II–IV) | Tissue | OS | Reported | 80 | | Hu et al. | 2016 | ESCC | China | 54.29 | Asian | R | SqCa | 133/72 (I-II/III-IV) | Plasma | OS | Reported | 60 | | Cai et al. | 2016 | Gallbladder cancer | China | 60 | Asian | R | AdenoCA | 17/23 (I-II/III-IV) | Tissue | NR | NR | NR | | Cai et al. | 2016 | Gallbladder cancer | China | 60 | Asian | R | AdenoCA | 13/22 (I-II/III-IV) | Tissue | OS | SC | 40 | | Yue et al. | 2016 | Colon cancer | China | 65 | Asian | R | AdenoCA | 66/68 (II/III) | Tissue | OS/DFS | Reported | 100 | | Chen et al. | 2016 | Gastric cancer | China | 60 | Asian | R | AdenoCA | 32/16 (I-II/III-IV) | Tissue | OS | Reported | 60 | | Ji et al. | 2015 | HCC | China | 60 | Asian | R | AdenoCA | 61/41 (I-II/III-IV) | Tissue | NR | NR | NR |
|
|
Study design is described as retrospective (R). AdenoCA, adenocarcinoma; SqCa, squamous carcinoma; OS, overall survival; DFS, disease-free survival; PFS, progression-free survival. ccRCC, clear cell renal cell carcinoma; ESCC, esophageal squamous cell carcinoma; HCC, hepatocellular carcinoma. NR, not reported; SC, survival curve.
|
